Formative Research on HPV Vaccine Acceptance among Health Workers, Teachers, Parents, and Social Influencers in Uzbekistan
- PMID: 37112666
- PMCID: PMC10142216
- DOI: 10.3390/vaccines11040754
Formative Research on HPV Vaccine Acceptance among Health Workers, Teachers, Parents, and Social Influencers in Uzbekistan
Abstract
Human papillomavirus (HPV) vaccines effectively prevent cervical cancer, most of which results from undetected long-term HPV infection. HPV vaccine introduction is particularly sensitive and complicated given widespread misinformation and vaccination of young girls before their sexual debut. Research has examined HPV vaccine introduction in lower- and middle-income countries (LMICs), but almost no studies attend to HPV vaccine attitudes in central Asian countries. This article describes the results of a qualitative formative research study to develop an HPV vaccine introduction communication plan in Uzbekistan. Data collection and analysis were designed using the Capability, Opportunity, and Motivation for Behaviour change (COM-B) mode for understanding health behaviours. This research was carried out with health workers, parents, grandparents, teachers, and other social influencers in urban, semi-urban, and rural sites. Information was collected using focus group discussions (FGDs) and semi-structured in-depth interviews (IDIs), and data in the form of participants' words, statements, and ideas were thematically analysed to identify COM-B barriers and drivers for each target group's HPV vaccine-related behaviour. Represented through exemplary quotations, findings were used to inform the development of the HPV vaccine introduction communication plan. Capability findings indicated that participants understood cervical cancer was a national health issue, but HPV and HPV vaccine knowledge was limited among non-health professionals, some nurses, and rural health workers. Results on an opportunity for accepting the HPV vaccine showed most participants would do so if they had access to credible information on vaccine safety and evidence. Regarding motivation, all participant groups voiced concern about the potential effects on young girls' future fertility. Echoing global research, the study results highlighted that trust in health workers and the government as health-related information sources and collaboration among schools, municipalities, and polyclinics could support potential vaccine acceptance and uptake. Resource constraints precluded including vaccine target-aged girls in research and additional field sites. Participants represented diverse social and economic backgrounds reflective of the country context, and the communication plan developed using research insights contributed to the Ministry of Health (MoH) of the Republic of Uzbekistan HPV vaccine introduction efforts that saw high first dose uptake.
Keywords: Uzbekistan; barriers; behaviour change; human papillomavirus; vaccine acceptance; vaccine introduction.
Conflict of interest statement
The authors declare no conflict of interest. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Why don't adolescent girls in a rural Uganda district initiate or complete routine 2-dose HPV vaccine series: Perspectives of adolescent girls, their caregivers, healthcare workers, community health workers and teachers.PLoS One. 2021 Jun 29;16(6):e0253735. doi: 10.1371/journal.pone.0253735. eCollection 2021. PLoS One. 2021. PMID: 34185805 Free PMC article. Clinical Trial.
-
Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.Reprod Health. 2022 Jun 10;19(1):136. doi: 10.1186/s12978-022-01444-4. Reprod Health. 2022. PMID: 35689288 Free PMC article.
-
Understanding parents' views toward the newly enacted HPV vaccine school entry policy in Puerto Rico: a qualitative study.BMC Public Health. 2021 Oct 25;21(1):1938. doi: 10.1186/s12889-021-11952-w. BMC Public Health. 2021. PMID: 34696745 Free PMC article.
-
Improving vaccination uptake among adolescents.Cochrane Database Syst Rev. 2020 Jan 17;1(1):CD011895. doi: 10.1002/14651858.CD011895.pub2. Cochrane Database Syst Rev. 2020. PMID: 31978259 Free PMC article.
-
National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.Vaccine. 2022 Mar 31;40 Suppl 1(Suppl 1):A2-A9. doi: 10.1016/j.vaccine.2021.04.025. Epub 2021 May 4. Vaccine. 2022. PMID: 33962839 Free PMC article. Review.
Cited by
-
A comprehensive narrative review of challenges and facilitators in the implementation of various HPV vaccination program worldwide.Cancer Med. 2024 Feb;13(3):e6862. doi: 10.1002/cam4.6862. Epub 2024 Jan 11. Cancer Med. 2024. PMID: 38213086 Free PMC article. Review.
-
Factors that influence caregivers' and adolescents' views and practices regarding human papillomavirus (HPV) vaccination for adolescents: a qualitative evidence synthesis.Cochrane Database Syst Rev. 2025 Apr 15;4(4):CD013430. doi: 10.1002/14651858.CD013430.pub2. Cochrane Database Syst Rev. 2025. PMID: 40232221 Free PMC article.
-
School Teachers' Perceptions of Adolescent Human Papillomavirus (HPV) Vaccination: A Systematic Review.Vaccines (Basel). 2024 Mar 27;12(4):361. doi: 10.3390/vaccines12040361. Vaccines (Basel). 2024. PMID: 38675743 Free PMC article. Review.
References
-
- WHO . Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. WHO; Geneva, Switzerland: 2020.
-
- WHO Human Papillomavirus Vaccines: WHO Position Paper, May 2017. Wkly. Epidemiol. Rec. 2017 May 20;92:241–268. - PubMed
-
- Bruni L., Albero G., Serrano B., Mena M., Gómez D., Muñoz J., Bosch F., Sanjosé S. Human Papillomavirus and Related Diseases Report: Uzbekistan. HPV Information Centre; Barcelona, Spain: 2019.
-
- Lee L.A., Franzel L., Atwell J., Datta S.D., Friberg I.K., Goldie S.J., Reef S.E., Schwalbe N., Simons E., Strebel P.M., et al. The Estimated Mortality Impact of Vaccinations Forecast to Be Administered during 2011–2020 in 73 Countries Supported by the GAVI Alliance. Vaccine. 2013;31:B61–B72. doi: 10.1016/j.vaccine.2012.11.035. - DOI - PubMed
-
- WHO . HPV Vaccine Communication. Special Considerations for a Unique Vaccine, 2016 Update. (WHO/IVB/17.02) World Health Organization; Geneva, Switzerland: 2017.
Grants and funding
LinkOut - more resources
Full Text Sources